Get Premium to unlock powerful stock data
Xencor Inc logo

Xencor Inc

$ 22.85 -0.13 (-0.57%) 12:15 PM EST
P/E:
13.04
P/B:
1.83
Market Cap:
$ 1.37B
Enterprise V:
$ 1.01B
Volume:
71.06K
Avg Vol (2M):
339.14K
Also Trade In:
Volume:
71.06K
Market Cap $:
1.37B
PE Ratio:
13.04
Avg Vol (2-Month):
339.14K
Enterprise Value $:
1.01B
PB Ratio:
1.83
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Xencor Inc
NAICS : 325412 SIC : 2834
111 West Lemon Avenue, Monrovia, CA, USA, 91016
Description
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Name Current Vs Industry Vs History
Cash-To-Debt 11.17
Equity-to-Asset 0.89
Debt-to-Equity 0.05
Debt-to-EBITDA 0.37
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.49
Distress
Grey
Safe
Beneish M-Score 1.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.95
9-Day RSI 38.5
14-Day RSI 39.08
6-1 Month Momentum % -28.05
12-1 Month Momentum % -34.7

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.3
Quick Ratio 8.3
Cash Ratio 6.4
Days Sales Outstanding 45.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.8

Financials (Next Earnings Date:2022-08-04 Est.)

XNCR's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:XNCR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 326.64
EPS (TTM) ($) 1.78
Beta 0.8
Volatility % 39.55
14-Day RSI 39.08
14-Day ATR ($) 1.49744
20-Day SMA ($) 25.001
12-1 Month Momentum % -34.7
52-Week Range ($) 21.98 - 43.61
Shares Outstanding (Mil) 59.54

Piotroski F-Score Details

Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Xencor Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More